GAUDIUM IVF N WOMEN H L

Operates a chain of in-vitro fertilisation (IVF) and women-health centres across India using a hub-and-spoke model, with 7 hubs and 28 spokes spread across 9 states as of FY26. Revenue comes from three streams: IVF treatment (64%), hospital services (31%), and pharmacy sales (4%). The business charges patients for fertility procedures, with average revenue per patient of Rs 2,97,998 and a reported 58% clinical pregnancy success rate on first IVF attempt. It differentiates using AI tools SiD (sperm assessment) and ERICA (embryo evaluation), developed with UK-based IVF 2.0, which it is rolling out into new centres. The largest cost lines are other operating expenses at 24.0% of revenue and employee costs at 7.7%, while materials cost is reported at 0% of revenue, consistent with a service-led model. FY26 consolidated revenue was Rs 104.36 crore with an EBITDA margin of 36.6%, down from 40.48% in FY25 as the company invested in expansion and AI deployment.